UCB and Biogen’s drug dapirolizumab pegol has met the primary endpoint of improvement in disease activity in lupus patients.

Preconception predictors of adverse pregnancy outcomes among women with SLE include previous lupus nephritis, chronic hypertension, SLE disease activity, and APS.

The following is a summary of “Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus,” ...

A study found that switching from rituximab to biosimilar CT-P10 is safe and effective for patients with systemic lupus ...

In the Phase III REGENCY study, Gazyva elicited superior complete renal response rates in patients with lupus nephritis ...

With a drug in advanced testing for two different indications that have spawned several blockbuster drugs, could Alumis be ...

The following is a summary of “Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes,” published in the September 2024 issue of Obstetrics and Gynecology by Moyle et al.

ONE year after being diagnosed with lupus at 21 and initially fearing that it meant an early end to her life, ‘lupus warrior’ ...

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

Estrogen activates cells that release antibodies, protein that mark and attack foreign ... Systemic autoimmune diseases, like systemic lupus erythematosus (SLE) and rheumatoid arthritis, affect ...

While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a serious complication of systemic lupus ...

The study finds a significant correlation between premature ovarian insufficiency and autoimmune diseases, urging further ...